| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.7M | — | +3774.4% |
| R&D Expense | $27.9M | -11.0% | +42.1% |
| SG&A Expense | $23.3M | +34.0% | +167.7% |
| Operating Income | -$51.1M | -4.9% | -80.7% |
| Net Income | -$43.8M | -5.8% | -114.7% |
| EPS (Basic) | -$0.57 | -5.6% | -90.0% |
| EPS (Diluted) | -$0.57 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $45.1M | +208.7% | +4.0% |
| Short-term Investments | $635.1M | -1.7% | +27.7% |
| Accounts Receivable | $515K | -8.4% | +275.9% |
| Inventory | $1.5M | — | — |
| Current Assets | $695.8M | +3.4% | +26.0% |
| Total Assets | $729.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$96.1M | — | — |
| Capital Expenditures | $127K | — | — |
| Investing Cash Flow | -$170.3M | — | — |
| Financing Cash Flow | $54.5M | — | — |
| Free Cash Flow | -$96.3M | — | — |
| -90.0% |
| +4.1% |
| +32.1% |
| Current Liabilities | $30.5M | +0.5% | +95.3% |
| Long-term Debt | $3.0M | — | — |
| Total Liabilities | $42.3M | +36.0% | +169.2% |
| Stockholders' Equity | $687.6M | +2.6% | +28.1% |